Table: begin end state 1 5 non-cytoplasmic 6 26 transmembrane 27 40 cytoplasmic 41 62 transmembrane 63 67 non-cytoplasmic 68 70 transmembrane 71 75 non-cytoplasmic 76 93 transmembrane 94 123 cytoplasmic 124 151 transmembrane 152 162 non-cytoplasmic 163 184 transmembrane 185 192 cytoplasmic 193 213 transmembrane 214 232 non-cytoplasmic 233 254 transmembrane 255 275 cytoplasmic 276 297 transmembrane 298 324 non-cytoplasmic 325 349 transmembrane 350 370 cytoplasmic 371 391 transmembrane 392 402 non-cytoplasmic 403 422 transmembrane 423 428 cytoplasmic 429 447 transmembrane 448 452 non-cytoplasmic 453 473 transmembrane 474 494 cytoplasmic
Input: >AO353_12815 MSASNPTLITFVIYIAAMVLIGFMAYRSTNNLSDYILGGRSLGSVVTALSAGASDMSGWL LMGLPGAIYMSGLSESWIAIGLIVGAYLNWLFVAGRLRVQTEHNGDALTLPDYFSSRFED KSGLLRIISAVVILVFFTIYCASGIVAGARLFESTFGMSYETALWAGAAATIAYTFVGGF LAVSWTDTVQATLMIFALLLTPIIVLLATGGIDTTFLAIEAQDPGNFDMLKNTSFIGIIS LMGWGLGYFGQPHILARFMAADSVKSIANARRISMTWMILCLGGTVAVGFFGIAYFSANP AVAMPVSENHERVFIELAKILFNPWIAGVLLSAILAAVMSTLSCQLLVCSSALTEDFYKS FLRKNASQVELVWVGRAMVLAVALIAIALAANPENRVLGLVSYAWAGFGAAFGPVVLISV LWKGMTRNGALAGIVVGALTVIVWKHFNLLGLYEIIPGFIFASLAILLVSKMGVPSAGML QRFAAAEKDFHLNK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server